Robert Hershberg
Director · 7 filings · Latest: Oct 6, 2026
Adaptive Biotechnologies Corp
AtaiBeckley Inc.
RECURSION PHARMACEUTICALS, INC.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
RXRX | Robert Hershberg | Director | Oct 6, 2026 | Sale | $5.00 | 25,000 | $125.0K | 162,156 | |
RXRX | Robert Hershberg | Director | Oct 6, 2026 | Option Exercise | $2.22 | 25,000 | $55.5K | 187,156 | |
RXRX | HERSHBERG ROBERT | — | Oct 6, 2026 | Proposed Sale | $5.00 | 25,000 | $125.0K | — | |
ADPT | Robert Hershberg | Director | Aug 18, 2026 | Sale | $24.40 | 30,664 | $748.2K | 46,683 | |
ADPT | Robert Hershberg | Director | Aug 18, 2026 | Option Exercise | $6.32 | 15,000 | $94.8K | 77,347 | |
ADPT | ROBERT M HERSHBERG | — | Aug 18, 2026 | Proposed Sale | $24.40 | 30,664 | $748.3K | — | |
ATAI | Robert Hershberg | Director | Jul 7, 2026 | Sale | $4.96 | 100,000 | $496.0K | 100,000 | |
ATAI | Robert Hershberg | Director | Jul 7, 2026 | Option Exercise | $1.35 | 100,000 | $135.0K | 100,000 | |
— | ROBERT HERSHBERG | — | Jul 7, 2026 | Proposed Sale | $4.96 | 100,000 | $496.0K | — | |
ADPT | ROBERT M HERSHBERG | — | Dec 10, 2025 | Proposed Sale | $16.00 | 22,968 | $367.5K | — | |
ADPT | HERSHBERG ROBERT | — | Mar 12, 2025 | Proposed Sale | $7.59 | 53,000 | $402.3K | — |